DE69940774D1 - Hla-bindende peptide und ihre verwendungen - Google Patents
Hla-bindende peptide und ihre verwendungenInfo
- Publication number
- DE69940774D1 DE69940774D1 DE69940774T DE69940774T DE69940774D1 DE 69940774 D1 DE69940774 D1 DE 69940774D1 DE 69940774 T DE69940774 T DE 69940774T DE 69940774 T DE69940774 T DE 69940774T DE 69940774 D1 DE69940774 D1 DE 69940774D1
- Authority
- DE
- Germany
- Prior art keywords
- hla
- peptides
- binding peptides
- immunogenic
- allele
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9858498A | 1998-06-17 | 1998-06-17 | |
PCT/US1999/013789 WO1999065522A1 (en) | 1998-06-17 | 1999-06-17 | Hla binding peptides and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69940774D1 true DE69940774D1 (de) | 2009-06-04 |
Family
ID=22269985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69940774T Expired - Lifetime DE69940774D1 (de) | 1998-06-17 | 1999-06-17 | Hla-bindende peptide und ihre verwendungen |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1089757B1 (de) |
JP (2) | JP2002518346A (de) |
AT (1) | ATE429247T1 (de) |
AU (1) | AU4577899A (de) |
CA (1) | CA2330824A1 (de) |
DE (1) | DE69940774D1 (de) |
ES (1) | ES2326146T3 (de) |
WO (1) | WO1999065522A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
DE19925199A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
DE19925235A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
GB9923309D0 (en) * | 1999-10-01 | 1999-12-08 | Glaxo Group Ltd | Assay |
WO2001041788A1 (en) * | 1999-12-10 | 2001-06-14 | Epimmune, Inc. | INDUCING CELLULAR IMMUNE RESPONSES TO p53 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
US20050287611A1 (en) * | 2004-05-07 | 2005-12-29 | Nugent C T Iv | MHC bridging system for detecting CTL-mediated lysis of antigen presenting cells |
US9249187B2 (en) | 2009-01-28 | 2016-02-02 | Epimmune Inc. | Pan-DR binding polypeptides and uses thereof |
KR20160037196A (ko) | 2013-07-31 | 2016-04-05 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 종양 연관된 탄수화물 항원을 표적으로 하는 암을 치료하고 예방하기 위한 조성물과 방법 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
US4690915A (en) | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
US4844893A (en) | 1986-10-07 | 1989-07-04 | Scripps Clinic And Research Foundation | EX vivo effector cell activation for target cell killing |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
ATE157012T1 (de) | 1989-11-03 | 1997-09-15 | Univ Vanderbilt | Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
US5972351A (en) * | 1992-04-03 | 1999-10-26 | Isis Innovation Limited | Plasmodium falciparum MHC class I-restricted CTL epitopes derived from pre-erythrocytic stage antigens |
JPH08501280A (ja) * | 1992-05-26 | 1996-02-13 | リュクスウニヴェルシテート レイデン | ヒトT細胞応答誘発組成物に用いるためのヒトp53タンパク質のペプチドおよびヒトp53タンパク質特異的細胞毒性Tリンパ球 |
IL105914A0 (en) | 1992-06-04 | 1993-10-20 | Univ California | Methods and compositions for in vivo gene therapy |
IL106610A0 (en) * | 1992-08-07 | 1993-12-08 | Cytel Corp | Hla binding peptides and their uses |
DE69435292D1 (de) * | 1993-03-05 | 2010-06-17 | Epimmune Inc | Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden |
WO1995007707A1 (en) | 1993-09-14 | 1995-03-23 | Cytel Corporation | Alteration of immune response using pan dr-binding peptides |
US5686068A (en) * | 1994-03-24 | 1997-11-11 | Ludwig Institute For Cancer Research | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof |
US6071890A (en) | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
JPH10510988A (ja) * | 1994-12-14 | 1998-10-27 | ザ スクリップス リサーチ インスティテュート | 腫瘍−特異的細胞毒性t細胞のインビボ活性化 |
US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
ATE244891T1 (de) * | 1996-04-26 | 2003-07-15 | Univ Leiden | Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope |
-
1999
- 1999-06-17 DE DE69940774T patent/DE69940774D1/de not_active Expired - Lifetime
- 1999-06-17 ES ES99928792T patent/ES2326146T3/es not_active Expired - Lifetime
- 1999-06-17 JP JP2000554400A patent/JP2002518346A/ja active Pending
- 1999-06-17 AU AU45778/99A patent/AU4577899A/en not_active Abandoned
- 1999-06-17 EP EP99928792A patent/EP1089757B1/de not_active Expired - Lifetime
- 1999-06-17 EP EP08018213A patent/EP2036573A1/de not_active Withdrawn
- 1999-06-17 CA CA002330824A patent/CA2330824A1/en not_active Abandoned
- 1999-06-17 WO PCT/US1999/013789 patent/WO1999065522A1/en active Application Filing
- 1999-06-17 AT AT99928792T patent/ATE429247T1/de not_active IP Right Cessation
-
2010
- 2010-01-12 JP JP2010004446A patent/JP2010090167A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2010090167A (ja) | 2010-04-22 |
EP1089757A1 (de) | 2001-04-11 |
WO1999065522A1 (en) | 1999-12-23 |
EP2036573A1 (de) | 2009-03-18 |
ES2326146T3 (es) | 2009-10-01 |
CA2330824A1 (en) | 1999-12-23 |
EP1089757B1 (de) | 2009-04-22 |
AU4577899A (en) | 2000-01-05 |
JP2002518346A (ja) | 2002-06-25 |
ATE429247T1 (de) | 2009-05-15 |
EP1089757A4 (de) | 2002-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE512666T1 (de) | Hla-bindende peptide und ihre verwendungen | |
ATE536187T1 (de) | Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen | |
BR9406652A (pt) | Composição | |
DE69334076D1 (de) | Hla bindepeptide und ihre verwendungen | |
DE69733352D1 (de) | Hla-a2.1 bindende peptide und deren verwendung | |
DK0941478T3 (da) | Assaymetode for peptidspecifikke T-celler | |
DE60142689D1 (de) | Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen | |
DE69834921D1 (de) | Antigen enthaltende zusammensetzung, die zusätzlich derivatisierte monoglyceride oder diglyceride als adjuvantien enthält | |
CY1108083T1 (el) | Αντιγονα και συνθεσεις του neisseria meningitidis | |
BR0017136A (pt) | Peptìdeos de ligação ao hla e seus usos. | |
DE69940774D1 (de) | Hla-bindende peptide und ihre verwendungen | |
ATE502952T1 (de) | Hla-bindungspeptide und ihre anwendungszwecke | |
WO2004007528A3 (en) | Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange | |
EP1605039A4 (de) | Dendritische zelle mit alpha-glycosylceramid-derivat und antigen zur verwendung bei der unterdrückung von immunreaktionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1089757 Country of ref document: EP Representative=s name: LEINWEBER & ZIMMERMANN, DE |
|
R081 | Change of applicant/patentee |
Ref document number: 1089757 Country of ref document: EP Owner name: BIOTECH SYNERGY, INC., US Free format text: FORMER OWNER: IDM PHARMA, INC., IRVINE, US Effective date: 20121016 |
|
R082 | Change of representative |
Ref document number: 1089757 Country of ref document: EP Representative=s name: LEINWEBER & ZIMMERMANN, DE Effective date: 20121016 |